Pharma Reviews: Opinion | Can covid-19 be Indian pharma's Y2K moment?

It also points to a once in a generation opportunity for Indian drug manufacturers as also the wider healthcare sector to become the dominant global ...
Read more: Opinion | Can covid-19 be Indian pharma's Y2K moment?